Illumina Posts Q3 Adjusted EPS of $1.62
ILMN has more than doubled off its 52-week low of $94.
Summary
Illumina reported third-quarter adjusted EPS of $1.62, beating the IBES estimate of USD 1.36, with adjusted EPS excluding tariff refunds at $1.44. GAAP EPS was $1.43 and net income was $220 million. Revenue rose to $1.13 billion but missed estimates, and the company raised its FY26 outlook. Context: Q2 revenue came in at $1.16 billion, up 9.5% year-over-year, with full-year guidance raised at the July 31 10-Q. The stock trades near $290 with a roughly $44 billion market value.
At the time of this announcement, ILMN was trading at $290.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $43.8B. The 52-week trading range was $94.00 to $309.35. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.